期刊文献+

多体素1H磁共振波谱在脑胶质瘤诊断及分级中的应用研究 被引量:2

Evaluation of 3.0T 1H-MR spectroscopy imaging in the diagnosis and grading of gliomas
原文传递
导出
摘要 目的探讨多体素1H磁共振波谱在脑胶质瘤诊断及分级中的价值。方法选取经手术病理或临床确诊的36例脑胶质瘤患者。采用美国GE公司SignaEXCITEHD3.0T超导型磁共振(MR)扫描仪对所有患者行颅脑常规核磁共振(MRI)扫描和二维多体素144ms序列扫描。采用Functool软件包后处理,分别测定病变实质、病变周围及健侧相应区域的胆碱(Cho)/肌酸(Cr)、Cho/N-乙酰天门冬氨酸(NAA)、NAA/Cr比值及肌醇(MI)值的变化,并对结果进行统计学分析。结果全组数据采用SAS8.2软件处理,结果显示:低级别胶质瘤和高级别胶质瘤瘤体区Cho/Cr、Cho/NAA、NAA/Cr比值及MI值分别比较差异有统计学意义(P〈0.05);瘤周水肿区Cho/Cr、NAA/Cr比值分别比较差异有统计学意义(P〈0.05),MI值比较差异无统计学意义(P〉0.05)。结论,H—MRS在鉴别诊断脑胶质瘤中有重要价值,结合MR其他成像方法可对其做出较为准确的分级。 Objective To investigate the value in MR spectrum of diagnosis and grading of gliomas. Methods 36 cases of patient with gliomas who confirmed by histopathologic findings or clinical follow-up were collected. Using a GE Signa EXCITE HD 3.0T super conduct MR unit, all the cases of patients were performed conventional MR scan and multi-voxel with 2-D muhi-voxel PRESS 144 ins. Functool software was used for post-processing of spectrum. The ratios of NAA/Cr, NAA/Cho, Cho/Cr were measured in the solid part of masses, eireum of tumors and contralateral parenchyma respectively. The result was processed by the statistical method. Results The statistical analysis was exacted by SAS 8.2 software. In the solid part of masses, there were significant differences between low-grade gliomas and high-grade gliomas in the ratios of Cho/Cr, Cho/NAA,NAA/Cr and M1 (P 〈0.05), but in peritumoral edema, there were significant differences in the ratios of Cho/Cr, NAA/Cr (P 〈0.05), and no significant differences in the ratios of MI (P 〈0.05). Conclusion 1H-MRS is very important and useful in the evaluation of gliomas. It has made it possible to exactly evaluate the grade of gliomas combined with other imagings.
出处 《肿瘤研究与临床》 CAS 2010年第4期250-254,共5页 Cancer Research and Clinic
关键词 肿瘤 神经上皮 磁共振波谱 诊断 鉴别 Neoplasms, neuroepithelial Magnetic resonance spectroscopy Diagnosis, differential
  • 相关文献

参考文献10

  • 1McKnight TR.Proton magnetic resonance spectroscopic evaluation of brain tumor.Metabolism Semin Oncol,2004,31:605-617.
  • 2Gonen O,Gruber S,Li BS.Multivoxel 3D proton spectroscopy in the brain at 1.5T versus 3.0T:Signal-to-noise ratio and resolution comparison.AJNR,2001,22:1727-1731.
  • 3Inoue T,Ogasawara K,Kumabe T,et al.Minute glioma identified by 3.0 Tesla magnetic resonance spectroscopy-case report.Neurol Med Chir(Tokyo),2005,45:108-111.
  • 4许茂盛,潘智勇,曹志坚,王伟,郑美君,倪桂宝.颅脑肿瘤强化周围区域的多体素氢质子波谱研究[J].中华放射学杂志,2003,37(12):1105-1110. 被引量:22
  • 5Andreas St,Stephan G,Christopher N,et al.Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.Radiology,2006,238:958-969.
  • 6Fountas KN,Kapsalaki EZ,Vogel RL,et al.Noninvasive histologic grading of solid astrocytomas using proton magnetic spectroscopy.Stereotact Funct Neurosurg,2004,82:90-97.
  • 7Kumar AJ,Leeds NE,Fuller CN,et al.Malignant gliomas MR imaging spectrum of radiation therapy-and chemotherapy-induced necrosis of the brain after treatment.Radiology,2000,217:377-384.
  • 8Law M,Cha S,Knopp EA,et al.High-grade gliomas and solitary metaatases:differentiation by using perfusion and proton spectroscopic MR imaging.Radiology,2002,222:715-721.
  • 9Morita K,Matsuzawa H,Fujii Y,et al.Diffusion tensor analysis of peritumoral edema using lambda chart analysis indicative of the heterogeneity of the microstructure within edema.J Neurosurg,2005,102:336-341.
  • 10Li X,Jin H,Lu Y,et al.Identification of MRI and 1H-MRSI parameters that may predict survival for patients with malignant gliomas.NMR Biomed,2004,17:10-20.

二级参考文献13

  • 1Ott D, Hennig J, Ernst T. Human brain tumors: Assessment with in vivo proton MR spectroscopy. Radiology, 1993, 186:745-752.
  • 2von Kienlin M, Ziegler A, Fur YL, et al. 2D-spatial/2D-spectral spectroscopic imaging of intracerebral gliomas in rat brain. Mag Res Med, 2000,43:211-219.
  • 3Bendszus M,Warmuth MM,Klein R, et al. MR spectroscopy in gliomatosis cerebri. AJNR, 2000, 21:375-380.
  • 4Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer, 1985, 56:1106-1111.
  • 5Burtscher IM, Skagerberg G, Geijer B, et al. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR, 2000,21:84-93.
  • 6Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology, 2002, 222:715-721.
  • 7Tamiya T, Kinoshita K, Ono Y, et al. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology, 2000, 42:333-338.
  • 8Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR, 2001, 22:604-612.
  • 9Kieffer SA, Chang JK. Intracranial neoplasms. In: Haaga JR, Lanzieri CF, Gilkeson RC, ed. CT and MR imaging of the whole body. 3 rd ed. St Louis: Mosby, 2003. 124-206.
  • 10Danielsen ER, Ross BD. Magnetic resonance spectroscopy diagnosis of neurological diseases. New York: Marcel Dekker, 1999.194-241.

共引文献21

同被引文献16

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部